iShares Genomics Immunology and Healthcare ETF(IDNA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IDNA iShares Genomics Immunology and Healthcare ETF

交易中 09-25 15:53:25 EDT

41.81

+0.12

+0.28%

最高41.83	最低41.21	成交量4.55万
今开41.66	昨收41.69	日振幅1.49%
总市值2.84亿	流通市值2.84亿	总股本680.00万
成交额189.54万	换手率0.67%	流通股本680.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":41.8085,"timestamp":1790366000910,"preClose":41.69,"halted":0,"volume":45455,"delay":0,"changeRate":0.0028424082513793356,"floatShares":6800000,"shares":6800000,"eps":0,"marketStatus":"交易中","change":0.1185,"latestTime":"09-25 15:53:25 EDT","open":41.66,"high":41.828,"low":41.205,"amount":1895387.1354999999,"amplitude":0.014944,"askPrice":41.89,"askSize":300,"bidPrice":41.62,"bidSize":300,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1790366400000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":41.69,"sharesOutstanding":5100000,"nav":40.638573,"aum":278374225.05,"dividendRate":0.00669,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":41.5,"preClose":41.69,"latestTime":"07:12 EDT","volume":2,"amount":83,"timestamp":1790334777796,"change":-0.19,"changeRate":-0.004557,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":41.69,"preClose":41.69,"latestTime":"19:30 EDT","volume":67,"amount":2795.48,"timestamp":1790292604105,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.248721,"impliedVol":0.1004,"impliedVolPercentile":0.1753},"requestUrl":"/m/hq/s/IDNA","defaultTab":"news","newsList":[{"id":"2669045569","title":"Anthropic：Claude主导发现了一种分子机器 可能代表一种新的基因编辑机制","url":"https://stock-news.laohu8.com/highlight/detail?id=2669045569","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669045569?lang=zh_cn&edition=full","pubTime":"2026-09-24 11:08","pubTimestamp":1790219336,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BMED","IDNA","XT","TARK","GNOM","KOMP","FWD","WDNA","SYNB","NBDS","HELX","DTEC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669587244","title":"Anthropic：Claude 识别新型酶系统，基因编辑股走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2669587244","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669587244?lang=zh_cn&edition=full","pubTime":"2026-09-24 09:37","pubTimestamp":1790213830,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，当地时间周三，Anthropic 宣布其模型 Claude 在海量 DNA 序列数据中识别出一种此前未被完整描述的酶系统，重复序列排列方式与 CRISPR 相似。这是其新设生物实验室的首项成果，团队于今年春季组建，实验室位于旧金山湾区。消息公布后，基因编辑公司股价周三走低，CRISPR Therapeutics 跌 5.54%，Beam Therapeutics 跌 6.02%，Prime Medicine 跌 11.58%。相关任务是从大型 DNA 数据库中寻找值得研究的逆转录酶系统。约 21 小时搜索中，约 950 个 Claude 智能体共使用约 2.1 亿个 token，其中一个智能体注意到某种逆转录酶基因旁有排列规律的重复 DNA 序列。团队将该组合命名为阵列相关逆转录酶系统，主要存在于噬菌体中，包含逆转录酶基因、相邻伴随基因及一组重复 DNA 序列。逆转录酶本身此前已有研究，新发现是它与周围非编码 DNA 序列及功能未知的伴随蛋白共同构成的系统。Anthropic 表示，研究人员仍不知道该系统的主要功能，也未证明它能像成熟基因编辑工具一样对 DNA 进行定向修改。初步实验发现这些重复序列能产生多种短 RNA，但这不等于已具备可编程基因编辑能力。预印本论文披露，为检验能否重复发现，团队又运行 10 次相同搜索； ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2291919","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","TARK","WDNA","NBDS","HELX","DTEC","SYNB","FWD","IDNA","GNOM","KOMP","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669843417","title":"Anthropic IPO前亮科研牌：Claude“自主发现”类CRISPR系统，基因编辑板块遭遇“AI替代焦虑”","url":"https://stock-news.laohu8.com/highlight/detail?id=2669843417","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669843417?lang=zh_cn&edition=full","pubTime":"2026-09-24 07:21","pubTimestamp":1790205689,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NBDS","ARKG","WDNA","BK4585","KCE","IDNA","HELX","BK4556","GNOM","TARK","DTEC","LU1861558580.USD","KOMP","LU1861559042.SGD","BK4127","AIPO","FWD","XT","BMED","CHAT","BK4139","REDS","AGIX","BK4611","ARTY","IPOS","FRHC","BK4588","CRSP","SYNB","QTOC","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669485869","title":"从技术并跑到落地困境，中国基因治疗的商业突围之路","url":"https://stock-news.laohu8.com/highlight/detail?id=2669485869","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669485869?lang=zh_cn&edition=full","pubTime":"2026-09-23 20:06","pubTimestamp":1790165189,"startTime":"0","endTime":"0","summary":"当前，基因治疗正站在一个尴尬的节点上：技术能力在加速，而支付与监管能力正在成为一个新的瓶颈。2026年，基因治疗的全球图景呈现明显的“两极分化”。在美国和欧洲，基因治疗的适应症持续扩展：美国食品药品监督管理局（FDA）将基因疗法Casgevy的适用年龄下调至2岁；欧盟批准了Itvisma覆盖更广泛的脊髓性肌萎缩症（SMA）人群。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609233882617632.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609233882617632.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["KOMP","BK4217","TARK","WDNA","BMED","IDNA","GNOM","FWD","NBDS","DTEC","XT","SMA","HELX","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669487698","title":"人类疯狂改造番茄，就为了让你吃到维生素D","url":"https://stock-news.laohu8.com/highlight/detail?id=2669487698","media":"虎嗅APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669487698?lang=zh_cn&edition=full","pubTime":"2026-09-23 18:53","pubTimestamp":1790160780,"startTime":"0","endTime":"0","summary":"最近几年，越来越多的科学家疯狂改造番茄，试图让它为人类生产维生素D。对人类来说，这属于暴殄天物，必须整改。在这篇研究中，约翰·英纳斯中心的科学家们还宣称，由于生化通路类似，除了番茄，同为茄科的马铃薯、辣椒也是生产维生素D3原料的潜力选手。吃这种番茄，已经快赶上直接吃复合维生素片了。所以，想要直接吃新鲜番茄补D3的人可能要失望了；这是最不能让人接受的，就是新鲜番茄仍然不含维生素D3。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MTQzMjE1NjQwMQ==&mid=2656207372&idx=3&sn=9706ce4606cfb02c82f1bab42fcf5ce6&chksm=677a3bb1d7b56cc09004ce87616d255d453911132b60fea923f3f7559a599b693034b8901db2&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["LU1633808545.USD","LU1496350171.SGD","IDNA","DIPS","LU0077335932.USD","TARK","NVDB","LU2083900584.USD","LU0234572021.USD","FWD","LU0170899867.USD","GNOM","LU1066051225.USD","NBDS","IPOS","NVDS","NVDL","HELX","LU0267386448.USD","KOMP","LU2265009873.SGD","NVII","NVD","LU1066051811.HKD","LU1066053197.SGD","07788","NVDQ","SYNB","WDNA","LU1066051498.USD","NVDG","NVC","LU0127658192.USD","BMED","ANV","LU0786609619.USD","07388","NVDU","LU0106261372.USD","NVDD","NVDY","NVDO","XT","LU1804176565.USD","LU1861127337.USD","NVDW","DTEC","LU1914381329.SGD","NVDX","NVYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669176439","title":"梅奥诊所实验室投资亚洲病理学控股公司和Lifestrands Genomics，以推进诊断和精准医疗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2669176439","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669176439?lang=zh_cn&edition=full","pubTime":"2026-09-23 09:30","pubTimestamp":1790127028,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BMED","IDNA","KOMP","WDNA","XT","SYNB","GDOC","DTEC","TYNE","GNMX","HTEC","GNOM","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669114208","title":"安进股价盘前大涨逾4%，受第三期临床试验结果提振。","url":"https://stock-news.laohu8.com/highlight/detail?id=2669114208","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669114208?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:07","pubTimestamp":1790082475,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BIB","LU2272731782.SGD","IBB","IYH","BBH","LU1992135472.HKD","PBPH","AMGN","SYNB","HELX","LFSC","LU2272731865.HKD","PBE","IEIH","XPH","LU0109394709.USD","PSCH","SBIO","CANC","GNOM","XBIX","LU0122379950.USD","TBXU","PJP","LU0058720904.USD","LU2473716301.USD","MRNY","AZNH","TMED","LU2242646821.SGD","IBBQ","BBP","IBRN","LU0320765992.SGD","FTXH","BK4599","MEDI","WDNA","IE00B4R5TH58.HKD","BME","BK4585","IE00B5TLWC47.USD","BIOY","PPH","IDNA","RSPH","RXL","IEHS","FBT","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198157419","title":"福泰制药宣布Inaxaplin在特定AMKD患者群体中取得积极结果，第13周UACR显著降低42.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198157419","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198157419?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:06","pubTimestamp":1790082369,"startTime":"0","endTime":"0","summary":"路透社9月22日消息——福泰制药 今日发布重大公告，披露其在APOL1介导肾病额外患者群体中开展的2b期AMPLIFIED研究取得积极成果。详细数据显示，对于伴有中度蛋白尿的AMKD患者，Inaxaplin在治疗第13周时使尿白蛋白肌酐比较基线下降了42.7%。两项研究队列均显示，Inaxaplin总体安全性和耐受性良好，未出现意外安全信号。值得注意的是，这是福泰制药在这两个特定亚群中首次公布Inaxaplin的临床数据，进一步拓展了该药物在AMKD治疗领域的潜在应用范围。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU1069344957.HKD","LU2462157665.USD","IDNA","IE00B4R5TH58.HKD","LU1035775433.USD","IE0009355771.USD","LU2468319806.SGD","LU2324357040.USD","LU0234570918.USD","IE00BJT1NW94.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU1093756325.SGD","LU0417517546.SGD","LU1778281490.HKD","LU1674673428.USD","LU2417539215.USD","LU0889565916.HKD","GNMX","LU1674673691.USD","IE00B894F039.SGD","LU0256863811.USD","LU1430594728.SGD","LU0061475181.USD","BK4532","PBE","LU2456880835.USD","BK4588","BK4567","SG9999001176.SGD","LU2362541513.USD","IBBQ","LU2237438978.USD","IE00BZ9MQY76.HKD","LU1093756168.USD","IE00B19Z3B42.SGD","LU2362540622.SGD","LU0320765992.SGD","LU0058720904.USD","BIB","IE00B19Z9P08.USD","SG9999013999.USD","IE00B19Z9Z06.USD","IE00BJJMRZ35.SGD","LU0079474960.USD","BK4139","LU2362541273.HKD","LU0109394709.USD","IE0002270589.USD","BK4533","VRTX","LU1585245621.USD","BBH","LU0432979614.USD","IE00BFTCPJ56.SGD","LU0823416689.USD","SG9999001176.USD","LU0289739699.SGD","LU2236285917.USD","IE00B19Z3581.USD","BK4585","IBB","LU2089984988.USD","SGXZ57979304.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162073525","title":"Forge Nano与Nanexa携手开发符合GMP标准的ALD制造设备","url":"https://stock-news.laohu8.com/highlight/detail?id=1162073525","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162073525?lang=zh_cn&edition=full","pubTime":"2026-09-22 20:54","pubTimestamp":1790081682,"startTime":"0","endTime":"0","summary":"9月22日（路透社）——Nanexa AB公司宣布，Forge Nano与Nanexa将联合开发适用于PharmaShell产品组合的GMP兼容原子层沉积（ALD）制造设备。\n这一重要合作涵盖了与Moderna的许可协议，以及多个未公开的制药合作项目。\n该设备的开发旨在满足制药行业对高质量、可规模化生产的需求，标志着两家公司在先进制造技术领域迈出了关键一步。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","MRNA","BK4568","BK4139","BK4588","MRNX","BK4501","BK4534","IDNA","LGHT","BK4548","BK4532","BK4551","GNOM","WDNA","MRNY","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196050236","title":"福泰制药：Inaxaplin在两种AMKD患者队列中均展现良好安全性与耐受性","url":"https://stock-news.laohu8.com/highlight/detail?id=1196050236","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196050236?lang=zh_cn&edition=full","pubTime":"2026-09-22 20:02","pubTimestamp":1790078535,"startTime":"0","endTime":"0","summary":"福泰制药近日披露，其候选药物Inaxaplin在两项针对APOL1介导肾病的临床试验队列中，表现出令人满意的安全性和耐受性特征。业内观察人士指出，Inaxaplin若能在后续研究中持续印证其价值，有望为AMKD这一难治性疾病带来突破性治疗选择。福泰制药此番公告，不仅回应了市场对管线进展的关切，也再次凸显了其在精准医疗赛道上的深耕意图。随着更多数据的积累，Inaxaplin的临床定位将愈发清晰，其对患者生活质量的实际改善程度也将接受更严苛的检验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","IE00B19Z3B42.SGD","IE00B19Z9Z06.USD","LU0432979614.USD","LU1430594728.SGD","IE0009355771.USD","LU2456880835.USD","SGXZ57979304.SGD","LU0109394709.USD","IE0002270589.USD","LU0079474960.USD","LU0061475181.USD","LU2362540622.SGD","LU2462157665.USD","TBXU","BK4567","LU2468319806.SGD","LU1093756325.SGD","LU0320765992.SGD","LU2236285917.USD","LU0058720904.USD","LU2362541273.HKD","LU2237438978.USD","LU1093756168.USD","IBBQ","LU1585245621.USD","LU0289739699.SGD","IDNA","IE00B2B36J28.USD","PBE","IE00BJJMRZ35.SGD","SG9999001176.USD","GNMX","LU0823416689.USD","IE0002141913.USD","IE00BZ9MQY76.HKD","BK4139","LU1674673428.USD","LU2324357040.USD","BK4585","LU2362541513.USD","BIB","LU0234570918.USD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","BK4532","IE00B894F039.SGD","IE00BFTCPJ56.SGD","LU1035775433.USD","IBB","LU1674673691.USD","SG9999001176.SGD","BBH","IE00BJT1NW94.SGD","LU0417517546.SGD","LU0256863811.USD","BK4588","LU1069344957.HKD","LU2417539215.USD","VRTX","LU1778281490.HKD","BK4533","LU2089984988.USD","SG9999013999.USD","IE00B19Z9P08.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160767959","title":"福泰制药公布Inaxaplin针对APOL1介导肾病（AMKD）其他人群的2B期AMPLIFIED研究积极结果，并完成2/3期AMPLITUDE试验入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1160767959","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160767959?lang=zh_cn&edition=full","pubTime":"2026-09-22 20:01","pubTimestamp":1790078494,"startTime":"0","endTime":"0","summary":"福泰制药今日宣布，其候选药物Inaxaplin在针对APOL1介导肾病其他患者群体的2B期AMPLIFIED研究中，取得了令人鼓舞的积极数据。与此同时，公司还确认，备受瞩目的2/3期AMPLITUDE注册试验已顺利达成全部患者入组目标。目前，该疾病在全球范围内缺乏针对性治疗手段，Inaxaplin有望为患者带来突破性的治疗选择。业内分析人士认为，AMPLIFIED研究的积极结果以及AMPLITUDE试验的顺利入组，进一步巩固了福泰制药在肾脏病精准医疗领域的领先地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IE0002141913.USD","IBB","LU0823416689.USD","IE00BJJMRZ35.SGD","LU1778281490.HKD","BBH","LU1674673691.USD","BK4532","LU2456880835.USD","SGXZ57979304.SGD","LU2362541273.HKD","LU2417539215.USD","LU1585245621.USD","PBE","IE00B894F039.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","GNMX","LU2089984988.USD","LU2462157665.USD","LU2236285917.USD","LU2362540622.SGD","VRTX","SG9999001176.SGD","IE00B2B36J28.USD","LU1430594728.SGD","LU2362541513.USD","LU2468319806.SGD","TBXU","LU0061475181.USD","BK4588","BK4567","LU0058720904.USD","LU1093756325.SGD","LU0417517546.SGD","LU2324357040.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0234570918.USD","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD","IBBQ","IE0009355771.USD","LU0432979614.USD","LU0889565916.HKD","SG9999001176.USD","IE00B19Z9P08.USD","LU0320765992.SGD","LU1093756168.USD","LU1069344957.HKD","LU1674673428.USD","SG9999013999.USD","IE00B4R5TH58.HKD","LU0079474960.USD","BK4585","LU0256863811.USD","LU1035775433.USD","LU2237438978.USD","IDNA","BK4139","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191181268","title":"福泰制药：Inaxaplin显著降低UACR达42.7%——针对适度蛋白尿APKD患者展现积极疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1191181268","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191181268?lang=zh_cn&edition=full","pubTime":"2026-09-22 20:01","pubTimestamp":1790078474,"startTime":"0","endTime":"0","summary":"生物制药巨头福泰制药近日披露了一项令人瞩目的临床数据：其候选药物Inaxaplin在治疗伴有适度蛋白尿的常染色体显性多囊肾病患者中，于第13周时使尿白蛋白肌酐比较基线大幅下降42.7%。值得关注的是，这项数据凸显了Inaxaplin在降低蛋白尿方面的显著潜力，而蛋白尿正是衡量肾脏损伤程度及预测疾病进展风险的关键生物标志物。尽管现有数据展现出鼓舞人心的信号，但业界普遍认为，要全面评估Inaxaplin的长期获益与安全性，尚需更大规模、更长周期的临床验证。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9Z06.USD","BK4532","PBE","LU1069344957.HKD","SG9999013999.USD","IE00BJJMRZ35.SGD","LU1674673691.USD","LU2456880835.USD","IDNA","VRTX","BIB","LU0320765992.SGD","GNMX","IE00B894F039.SGD","IE00BZ9MQY76.HKD","LU2362541273.HKD","LU2468319806.SGD","IE00B19Z9P08.USD","IE00B19Z3581.USD","BBH","LU2362540622.SGD","LU0109394709.USD","LU1585245621.USD","LU2362541513.USD","LU2089984988.USD","LU0256863811.USD","LU0289739699.SGD","LU0823416689.USD","IE00B4R5TH58.HKD","SGXZ57979304.SGD","LU2324357040.USD","IE0009355771.USD","LU1430594728.SGD","SG9999001176.SGD","IE00BFTCPJ56.SGD","BK4567","IE00B19Z3B42.SGD","LU0079474960.USD","LU1093756168.USD","LU2237438978.USD","LU0061475181.USD","LU0432979614.USD","IE00B2B36J28.USD","BK4585","LU1093756325.SGD","LU0234570918.USD","LU2462157665.USD","LU0417517546.SGD","LU2236285917.USD","IBB","BK4533","IE0002141913.USD","BK4139","LU0889565916.HKD","SG9999001176.USD","TBXU","LU2417539215.USD","BK4588","LU0058720904.USD","LU1778281490.HKD","LU1035775433.USD","IE00BJT1NW94.SGD","IBBQ","IE0002270589.USD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669191213","title":"美股盘后：存储概念股普涨，SK海力士涨超1%，美光科技 、闪迪等上涨；亚马逊、特斯拉 、谷歌拉升","url":"https://stock-news.laohu8.com/highlight/detail?id=2669191213","media":"经纬科创","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669191213?lang=zh_cn&edition=full","pubTime":"2026-09-22 08:26","pubTimestamp":1790036760,"startTime":"0","endTime":"0","summary":"北京时间9月22日，美股周一盘后时段，三大股指期货表现分化。截至发稿，道指期货跌0.02%，纳指期货涨0.21%，标普500指数期货涨0.03%。美国科技七巨头盘后涨跌不一，苹果跌0.05%，亚马逊涨0.26%，Meta跌0.1%，微软跌0.06%，英伟达跌0.02%，特斯拉涨0.07%，谷歌涨0.35%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://stock.eastmoney.com/a/202609223880645857.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/a/202609223880645857.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GOOX","AIPI","LU0726765562.USD","LU2168564495.EUR","SMETAmain","TYLG","LU2102340556.USD","LU1429558221.USD","LU0157215616.USD","AAPE","LU1629891620.HKD","LU1064131342.USD","LU1935043023.USD","LU0094547139.USD","LU1232071149.USD","LU1914381329.SGD","LU1989763005.USD","LU2168564065.EUR","LU2381873111.SGD","SKHX","SGXZ51526630.SGD","LU0211331839.USD","LU1301847155.USD","LU1144417596.USD","BK4512","LU0289961442.SGD","LU0061474705.USD","LU1861559042.SGD","NVD","LU1116320737.USD","NVDX","TESC","HK0000914660.USD","LU2430703095.HKD","LU1236620834.HKD","LU0320765059.SGD","LU0784385170.HKD","IE00B894F039.SGD","LU1043141123.HKD","LU1366192091.USD","LU0345768740.USD","IE00B19Z8W00.USD","LU1923622291.USD","LU1032955483.USD","AAPW","LU1633808545.USD","LU1989764664.SGD","LU1066051498.USD","LU1316542783.SGD","SG9999015341.SGD","LU0072461881.USD","IE00B5949003.HKD","SG9999004303.SGD","SMOG","LU0757359368.USD","SG9999015978.USD","SKHA","IE00BZ199S13.USD","LU0690374615.EUR","LU2063271972.USD","LU0426412945.USD","LU2506951958.HKD","NVDS.UK","IE00BMPRXR70.SGD","LU0724617625.USD","LU0648001328.SGD","LU1506573853.SGD","LU1551013342.USD","SHOC","TDIV","LU2083900584.USD","BK4555","IE000M9KFDE8.USD","LU0256863902.USD","LU1815336760.USD","IE00B3SWFQ91.USD","LU2326559502.SGD","TSLR","LU1181866309.USD","LU1035773651.USD","LU1244550577.SGD","3NVD.UK","AIFD","LU1043141396.HKD","LU1699723380.USD","LU2242650005.HKD","LU2433249047.HKD","LU2237957902.USD","LU2602419157.SGD","LU2125909916.SGD","LU0210533765.USD","LU1989771016.USD","LU1046421795.USD","LU1883839398.USD","LU1935042488.USD","LU0476273544.USD","LU1935043536.SGD","LU2361045086.USD","LU2106854487.HKD","MRNA","LU1791710400.SGD","MSFU","NVDA","BK4576","LU2458330243.SGD","LU0456855351.SGD","LU0122379950.USD","LU0342679015.USD","STXX","BK4514","LU0861579265.USD","LU1670756490.USD","IE00BJTD4N35.SGD","LU0894486033.HKD","LU2417539215.USD","LU0048573561.USD","LU1868837136.USD","AMZY","LU2247934214.USD","IE0004445015.USD","SG9999000418.SGD","SKDD","BK4604","AIQ","LU0225771236.USD","LU0784385840.USD","LU0198837287.USD","LU0077335932.USD","IE00B7KXQ091.USD","LU1066051225.USD","LU1983260115.SGD","LU1992135472.HKD","LU0211328371.USD","BK4524","LU0889565833.HKD","07788","IE000Q6AESB8.SGD","LU0823397103.USD","SG9999017495.SGD","BAI","LU1267930813.SGD","SMU00main","IE00BZ1G4Q59.USD","IE00BLSP4239.USD","AAPB","LU1894683348.USD","BK4528","LU0081259029.USD","LU0154236417.USD","LU0274383776.USD","LU2360032135.SGD","THMR","IE00B775SV38.USD","LIT","LU0210536198.USD","LU0321505439.SGD","LU1691799644.USD","SG9999014542.SGD","LU0426417589.USD","RTH","LU1188199696.SGD","TSL","SG9999014880.SGD","SKHQ","LU2322448791.USD","VOX","FDRV","LU0683600562.USD","LU0203347892.USD","LU0742534661.SGD","LU2249611893.SGD","AAPD","ILDR","LU0882574139.USD","LU0994945656.USD","LU1548497426.USD","CLSE","LU2491050154.USD","MU","IE00BHPRN162.USD","LU0057025933.USD","LU2213496289.HKD","WATS","IE000SO60NU8.SGD","LU0879622024.SGD","LU2028103732.USD","SG9999015986.USD","LU0079474960.USD","HYNX","LU1564329628.SGD","LU1032466523.USD","SG9999013999.USD","LU0316494557.USD","LU0203202063.USD","LU1202635105.USD","LU1235294995.USD","IE00B4YYXB79.USD","IOSX","STXL","LU0353189763.USD","LU0823397285.USD","LU1917777945.USD","SG9999001176.USD","IE000BZT7R73.USD","LU0949170772.SGD","LU0719512351.SGD","LU2552382215.SGD","TSLY","MSFO","LU0795875169.SGD","LU2361044865.SGD","CHPS","GOOG","GNOM","MUU","LU2290526834.HKD","LU1868837300.USD","SG9999014898.SGD","LU0985320562.USD","LU1951200564.SGD","SKUU","LU2272731600.USD","LU1823568750.SGD","LU0353189680.USD","IE00B4JS1V06.HKD","NVDW","ABFL","BK4561","AGOX","AIS","SG9999014567.USD","SOXX","FXL","LU0276348264.USD","TSLL","LU0345770993.USD","LU2357125470.USD","LU1803068623.USD","LU0466842654.USD","LU1804176565.USD","LTL","NVDD","LU2168564149.EUR","SOXQ","LU2294711713.HKD","LU2089283258.USD","NVDS","BK4592","LU1674673428.USD","DRMY","LU1564329032.USD","LU1992135399.USD","LU2461242641.AUD","CHPX","LU0240878834.USD","LU2471134879.HKD","LU0225284248.USD","LU1066051811.HKD","LU1974910355.USD","BK4507","LU1670711123.USD","BK4566","IE00B1BXHZ80.USD","SG9999001424.SGD","BK4503","LU1670711040.USD","SKHZ","LU1496350171.SGD","BK4077","BK4097","LU0792757196.USD","LU0225283273.USD","LU0314104364.USD","BK4571","IE00BWXC8680.SGD","METG","FAI","BK4220","IE0009356076.USD","LU2471134523.USD","IE00B5TLWC47.USD","IE00BMPRXN33.USD","SAAPLmain","LU2637965513.SGD","FBL","TSLS","OZEM","LU0095938881.EUR","SGOOGmain","LU1069344957.HKD","LU1674673691.USD","LU2596442595.SGD","MSFL","IE00B3M56506.USD","LU2065171311.SGD","LU0056508442.USD","QQQG","LU1267930573.SGD","LU0127658192.USD","LU2095319765.USD","LU2092627202.USD","LU2272731782.SGD","LU2244417387.USD","BK4504","LU0203345920.USD","LU0472753341.HKD","LU2275660780.HKD","LU2552382132.HKD","LU2756315318.SGD","LU2999663052.SGD","FCOM","LU1551013425.SGD","LU0417517546.SGD","LU1670710661.SGD","LU1821325948.USD","LU1868836914.USD","LU2746668974.SGD","LU0494093205.USD","LU0138981039.USD","BK4527","LU0097036916.USD","LU2210150020.SGD","LU0979878070.USD","PSI","LU0011850046.USD","LU0321505868.SGD","FBY","LU0965509010.AUD","LU0964807845.USD","LU1951198990.SGD","LU0323591593.USD","LU2458330169.SGD","IE00B3S45H60.SGD","BK4599","LU0985489474.SGD","SPTE","LU0943347566.SGD","FTXL","LU0738911758.USD","CNEQ","LU1496350502.SGD","LU0170899867.USD","LU1839511570.USD","LU1585245621.USD","07709","FBX","BK4579","LU0130103400.USD","IE00B19Z9P08.USD","ESLG","LU0957791311.USD","LU0128525929.USD","LU2505996509.AUD","LU2506952170.USD","MACW.SI","IE00B7SZLL34.SGD","LU0082616367.USD","LU2237438978.USD","LU1074936037.SGD","SMHX","AMZD","LU2764263039.SGD","SGXZ80539844.SGD","SGXZ57979304.SGD","WDC","WUGI","XNTK","METV","HBMX","LU2023250504.SGD","LU1923623000.USD","LU1564329461.SGD","LU2463028550.USD","LU2191332357.HKD","LU1712237335.SGD","SOCL","IE00BJJMRX11.SGD","IE00BQXX3C00.GBP","IE000WAW04H5.SGD","LU1201861165.SGD","IE0004086264.USD","IE00BD6J9T35.USD","NVDQ","LU0985481810.HKD","HK0000819398.USD","MSFC","LU1852331112.SGD","LU2322448957.HKD","LU2125909759.SGD","STSLAmain","IDNA","SMH","LU0251131958.USD","NVD2.UK","IE00BLSP4452.SGD","IE00BQXX3F31.USD","SG9999011175.SGD","IE00BDCRKT87.USD","SGXZ44715902.SGD","OGIG","LU0345769631.USD","LU0395794307.EUR","LU1023059063.AUD","LU1291159041.SGD","BK4139","LU1732800096.USD","BK4614","LU2237443622.USD","LU2092937221.SGD","BK4515","APLY","LU0444971666.USD","LU0784384876.USD","LU2362541513.USD","LU1334329650.SGD","LU2092937148.SGD","TRUC","META","LU1989773731.SGD","BK4598","ESUM","LU1242518931.SGD","LU2148611432.USD","LU2236285917.USD","LU2404859667.USD","BK4505","LU0109392836.USD","LU0312595415.SGD","LU2087625088.SGD","ROM","LU0211327993.USD","LU2896262040.SGD","LU0289960550.SGD","LU0823414551.USD","LU2237443549.SGD","GB00B4LPDJ14.GBP","LU2237443382.USD","LU0820561909.HKD","LU1670628061.USD","CHAT","SG9999014906.USD","LU1934455277.USD","VGT","LU1206712785.SGD","BK4548","LGHT","LU0788109477.HKD","LU0965508806.USD","LU0823413660.USD","LU1066053197.SGD","LU0314106906.USD","LU2111349929.HKD","LU0238689110.USD","TSLQ","TSLW","LU0208291251.USD","LU1934455863.HKD","LU1989772840.SGD","LU0048584097.USD","LU0672654240.SGD","LU0266013472.USD","LU1582987597.SGD","IE0003U64NQ7.SGD","LU2298321311.HKD","LU1803068979.SGD","TTXU","IE00BYQQ9H92.USD","SG9999014914.USD","BK4605","LU2125154935.USD","LU2250418816.HKD","IE0004445239.USD","IE00B19Z9Z06.USD","LU2125154778.USD","CLIX","METD","LU0267386448.USD","BK4612","LU0552385451.USD","GOOP","LU2047632596.USD","LU2592432038.USD","LU2054465674.USD","09388","BK4559","RSPC","LU1201861249.SGD","LU2491050071.SGD","BK4581","LU0289941410.SGD","SKHYV","BK4551","LU1400636574.HKD","LU1267930730.SGD","AMZO","HK0000914686.HKD","LU0823421333.USD","LU0234570918.USD","IE000W1ABFV2.USD","LU0784383803.USD","IE00B1XK9C88.USD","LU1894683264.USD","USJW.SI","LU0306807586.USD","EMSF","SAMZNmain","2NVD.UK","LU0345769128.USD","LU1069347547.HKD","TLA","LU1145028129.USD","LU2089985449.USD","NVII","SG9999015952.SGD","LU2286300806.USD","SNVDAmain","LU0950375773.USD","SGXZ99366536.SGD","LU0345774391.USD","AMZW","TEST","LU2462591277.SGD","LU2750360997.AUD","LU0310800379.SGD","LU0557290698.USD","LU0965509101.SGD","IE00BYXW3230.USD","LU0965509283.SGD","LU3102509885.SGD","ANV","TRFK","LU2462591350.SGD","HK0000320223.HKD","AMAA","LU0528227936.USD","LU2089284900.SGD","METW","LU2487616109.SGD","GB00BDT5M118.USD","BK4538","LU2271345857.HKD","LU1037948541.HKD","LU1670710588.SGD","LU0320765489.SGD","LU0124676726.USD","MUD","NVIW.SI","TSLG","BK4574","LU1206713676.USD","BK4529","LU1280957306.USD","MSFT","AMZZ","LU1037948897.HKD","LU0511384066.AUD","BK4587","LU1582986359.USD","AMZP","LU1196500208.SGD","FBYY","LU0006306889.USD","LU0158827948.USD","LU2087621335.USD","LU1880398554.USD","LU1935043452.HKD","BK4575","EGGY","IE0004091025.USD","LU0080751232.USD","CGGO","LU0203201768.USD","IE000F7OJYX1.SGD","LU2506951875.HKD","LU2552382058.USD","LU2860962120.EUR","SG9999002224.SGD","IGV","LU1935042991.SGD","COWG","MSFY","SOXY","LU0823417737.USD","LU0868494708.USD","LU0553294199.USD","LU0345774631.USD","GAMR","LU0786609619.USD","LU1489326972.SGD","LU0143551892.USD","AMZU","IE0009G5SDU7.USD","LU0545562505.USD","LU0894485498.HKD","LU1582987324.SGD","IE00BN29S564.USD","IE0005OL40V9.USD","LU0215105999.USD","LU0289739343.SGD","LU0823414478.USD","LU1989772923.USD","MIC","RULE","BK4511","LFGY","SG9999014559.SGD","HULL","LU1059921491.USD","LU1989764748.USD","09766","IE00BKPKM429.USD","LU1642822529.SGD","SG9999018857.SGD","LU0068578508.USD","LU1791710582.SGD","LU1778281490.HKD","LU1861558580.USD","BK4534","LU0106261372.USD","LU0289739699.SGD","FDTX","LU0096364046.USD","LU0302445910.USD","LU1267930490.SGD","LU1623119135.USD","AZYY","LU2357305700.SGD","LU2543165471.USD","WDNA","SG9999018865.SGD","LU0107464264.USD","TSLO","LU0960925559.SGD","SGXZ81514606.USD","TSLA","LU0061475181.USD","BK4596","LU0251132253.USD","BK4554","LU1228905037.USD","SG9999015945.SGD","JGRO","LU0133085943.USD","LU1934455194.USD","LU2100268510.USD","IE0034235188.USD","LU2264538146.SGD","LU0898699433.AUD","IXN","BK4550","LU2237443465.HKD","QQQA","LU0109391861.USD","IE00BK4W5L77.USD","LU0256863811.USD","BK4585","LU0757359954.USD","IE000KEQY171.SGD","LU1732799900.SGD","LU0949170426.SGD","LU0444973449.USD","LU0820561818.USD","BOBP","LU1697837992.HKD","LU1923622614.USD","AAPX","LU2413666426.HKD","BK4122","LU2452424414.USD","AAPL","LU1127390331.HKD","LU1057294990.SGD","LU0072462426.USD","IE00BQXX3D17.EUR","LU2065169927.USD","VT","IE00BFSS7M15.SGD","IETC","LU2360108059.USD","XLK","BK4543","LU1366333091.USD","LU0871640123.AUD","LU2764263203.CNY","BK4573","LU2954938101.SGD","LU2347655156.SGD","LU0642271901.SGD","EFIV","LU2931357623.SGD","BK4533","BK4577","LU0149725797.USD","LU2237957811.SGD","LU2279689827.SGD","LU0058720904.USD","LU1645745479.HKD","SKHU","BK4501","GB00B4QBRK32.GBP","LU0130102774.USD","PFE","LU0787776722.HKD","LU1323610961.USD","LU0061474960.USD","MSFW","MUZ","BK4567","LU2471134796.USD","LU1400636491.USD","LU2077746001.SGD","SGXZ23171101.USD","LU2125909593.SGD","LU0323240290.USD","LU2430703251.USD","LU0070217475.USD","ARTY","ONLN","BK4170","SG9999015358.SGD","LU2404859741.USD","TSDD","LU2360106780.USD","LU0889566641.SGD","BK4007","LU0174119429.USD","LU2746668461.USD","LU1868836757.USD","LU0265550946.USD","AMZN","IE00BFXG0V08.USD","IE0001KFT4U8.USD","LU0689472784.USD","09788","09366","LU1814569148.SGD","LU0070302665.USD","LU0308772762.SGD","LU2394011477.USD","LU1880398471.USD","LU0053666078.USD","LU2362540622.SGD","LU0640476718.USD","LU2764262908.HKD","TTEQ","IE0002270589.USD","LU2471134952.CNY","IE00BN8TJ469.HKD","TEK","CNAV","LU0823411888.USD","LU0859254822.USD","IE00B775H168.HKD","LU0433182093.SGD","LU0823434583.USD","LU1084165304.USD","LU1988902786.USD","LU2211815571.USD","IDRV","BK4525","LU0234572021.USD","LU2462157665.USD","LU1035775433.USD","NVYY","LU0210528500.USD","CMAG","AAPY","LU0957808578.USD","LU2108987350.USD","LU2362541273.HKD","LU2272731865.HKD","AAPU","BK4099","LU2357627491.SGD","IE00BJJMRY28.SGD","LU0912757837.SGD","LU1261432733.SGD","LU0661504455.SGD","LU0006061336.USD","LU1119994496.HKD","LU1861127337.USD","LU1868836591.USD","SG9999001077.SGD","XDAT","LU0348723411.USD","NVDU","IE00BJLML261.HKD","LU0171293334.USD","LU0345768153.USD","LU0823417653.USD","WDCC","LU1153585028.USD","METU","LU0354030511.USD","GXPC","LU0158827781.USD","LU2505996681.GBP","MULL","LU2720916845.USD","IE00BSNM7G36.USD","SNPE","LU0690374961.EUR","LU0795875086.SGD","LU0820562030.AUD","LU1720051017.SGD","BK4608","07388","LU1236620750.USD","LU1116320901.HKD","LU2097344431.USD","LU2210149790.SGD","MRNX","HK0000306701.USD","HK0000320264.USD","07366","IE00BKVL7J92.USD","STXU","USAW.SI","LU2242649171.HKD","MUYY","LU0878866978.SGD","BK4532","IE00BBT3K403.USD","LU1221951046.USD","LU1582986433.USD","LU2456880835.USD","LU0265550359.USD","LU2097344357.USD","LU2023250330.USD","IE0034235303.USD","LU0029864427.USD","LU1721428933.USD","LU2491049909.HKD","LU2506952097.USD","LU0823434740.USD","MSFD","NVDB","BK4535","LU2133065610.SGD","IE00B3T34201.USD","LU0708995401.HKD","SKHN","LU1430594728.SGD","LU0648000940.SGD","LU1571399168.USD","LU2420271590.USD","LU0175139822.USD","HK0000304805.HKD","LU2756315664.SGD","BK4568","BK4553","MUG","STX","NVDO","IE00BKDWB100.SGD","TSLP","IE000ITXATA3.USD","LU0306806265.USD","IE00B19Z9505.USD","LU1718418525.SGD","NVDY","WDCX","LU2265009873.SGD","LU2360107168.USD","IE000MB6IJN5.SGD","LU1221951129.SGD","LU1815333072.USD","LU1340139317.AUD","WISE","NVC","LU0069063385.USD","TSII","SG9999001176.SGD","LU2041044095.USD","LU2750360641.GBP","LEGR","LU2065171402.SGD","IE00B19Z3B42.SGD","DISK","IE00BJTD4V19.USD","LU1935042215.USD","SKHL","TESL","LU0545039389.USD","LU1235295455.SGD","LU0240877869.USD","LU1244550221.USD","WANT","BK4602","METQ","LU1244550494.USD","LU0708994859.HKD","IE00B19Z8X17.USD","LU1956131251.USD","BK4549","HK0000306685.HKD","IE00BFSS8Q28.SGD","TSYY","WLDR","FCUS","IE00BDRTCR15.USD","XLC","LU2065170008.USD","LU1979441026.SGD","SG9999003800.SGD","LU0354030438.USD","DIPS","IE00B19Z3581.USD","LU2048586759.USD","NVDL","LU2237443978.SGD","CRSH","LU2097829019.USD","LU2361044949.HKD","LU1941712348.USD","SNVD.UK","LU0187121727.USD","LU1400636657.SGD","07766","HK0000532082.HKD","AMZG","LU1861215975.USD","LU0868494617.USD","LU2506951792.HKD","LU0942090050.USD","LU2413666699.HKD","LU2168564222.USD","MRNY","SGXZ31699556.SGD","LU0390134368.USD","LU2317271919.USD","LU1003077747.HKD","USXF","FTEC","LU0096362180.USD","BK4516","MSFX","NULC","LU0689626769.HKD","LU2023251221.USD","LU2211817866.USD","LU2347655073.USD","TSLZ","IE00BFXG1179.USD","USD","TSLT","LU0162691827.USD","LU1121112475.USD","LU2237443895.HKD","LU1720051108.HKD","BK4141","LU1861220033.SGD","LU0823421416.USD","LU1941712264.USD","LU1242518857.USD","IE0034235295.USD","LU0823413587.USD","LU2430703178.SGD","LU2023250843.SGD","LU0251142724.SGD","LU0323239441.USD","LU1228905540.USD","NVDG","PTF","LU1435385759.SGD","LU2473716301.USD","SG9999002232.USD","SG9999014575.USD","SKHY","IE00BK4W5M84.HKD","HK0000304797.USD","LU2168563687.JPY","TSLI","BK4588","ELOL","LU1564329115.USD","NVD3.UK","LU0980610538.SGD","LU0345770308.USD","SMSFTmain","IE0000B7K699.USD","LU0347712357.USD","LU2403377893.USD","LU2125909247.SGD","IE000YTNTUN2.SGD","LU0310799852.SGD","IE00BMPRXQ63.HKD","LU1670627923.USD","SK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147475205","title":"福泰制药获Leerink Partners恢复覆盖，给予跑赢大盘评级及594美元目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1147475205","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147475205?lang=zh_cn&edition=full","pubTime":"2026-09-21 18:04","pubTimestamp":1789985058,"startTime":"0","endTime":"0","summary":"Leerink Partners近日宣布恢复对福泰制药的覆盖研究，并给予该股\"跑赢大盘\"评级。这家华尔街投行同时将目标价设定为594美元，彰显其对福泰制药未来走势的乐观预期。这一动作引发市场广泛关注——毕竟，Leerink Partners在生物医药领域的分析素以严谨著称。其恢复覆盖并给出积极评级，无疑为投资者注入了一针强心剂。值得注意的是，这一评级决定恰逢生物科技板块整体回暖之际。多重因素交织下，福泰制药的股价表现或将迎来新的催化剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IE0002141913.USD","IBB","LU0823416689.USD","IE00BJJMRZ35.SGD","LU1778281490.HKD","BBH","LU1674673691.USD","BK4532","LU2456880835.USD","SGXZ57979304.SGD","LU2362541273.HKD","LU2417539215.USD","LU1585245621.USD","PBE","IE00B894F039.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","GNMX","LU2089984988.USD","LU2462157665.USD","LU2236285917.USD","LU2362540622.SGD","VRTX","SG9999001176.SGD","IE00B2B36J28.USD","LU1430594728.SGD","LU2362541513.USD","LU2468319806.SGD","TBXU","LU0061475181.USD","BK4588","BK4567","LU0058720904.USD","LU1093756325.SGD","LU0417517546.SGD","LU2324357040.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0234570918.USD","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD","IBBQ","IE0009355771.USD","LU0432979614.USD","LU0889565916.HKD","SG9999001176.USD","IE00B19Z9P08.USD","LU0320765992.SGD","LU1093756168.USD","LU1069344957.HKD","LU1674673428.USD","SG9999013999.USD","IE00B4R5TH58.HKD","LU0079474960.USD","BK4585","LU0256863811.USD","LU1035775433.USD","LU2237438978.USD","IDNA","BK4139","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667985488","title":"丹纳赫（DHR）旗下两子公司联合推出Cas9 mRNA解决方案 赋能基因编辑研发加速落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2667985488","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667985488?lang=zh_cn&edition=full","pubTime":"2026-09-16 20:57","pubTimestamp":1789563457,"startTime":"0","endTime":"0","summary":"金吾财讯 | 丹纳赫 旗下两家子公司——集成DNA技术公司与Aldevron宣布推出联合研发的科研级S.p. Cas9 mRNA解决方案，涵盖野生型及SpyFi高保真两种形式，旨在加速CRISPR基因编辑项目从早期研究向符合CGMP标准的临床开发转型。该联合方案结合了IDT在CRISPR基因工程与设计方面的专业知识，以及Aldevron在mRNA领域的规模化生产能力。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/ZmFlOWFhNTNlYzgzMTc4NTEyNzIzMzYzNzY2.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZmFlOWFhNTNlYzgzMTc4NTEyNzIzMzYzNzY2.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306117","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2106854487.HKD","NBDS","LU1551013342.USD","GNOM","LU0882574055.USD","BMED","LU0528227936.USD","DTEC","LU0114720955.EUR","LU0289960550.SGD","LU1551013425.SGD","KOMP","SYNB","XT","LU0432979614.USD","DHR","IE00BQXX3C00.GBP","HELX","LU0390134368.USD","IE000M9KFDE8.USD","LU2063271972.USD","LU2125910336.SGD","LU1804176565.USD","ARKG","LU0820561818.USD","LU1791710582.SGD","BK4585","LU0289961442.SGD","LU2355687059.USD","LU1267930730.SGD","IDNA","BK4534","LU0289739343.SGD","FWD","LU0708995401.HKD","LU1974910355.USD","SGXZ57979304.SGD","LU0689472784.USD","LU1923622614.USD","LU2211814178.USD","WDNA","IE00BQXX3F31.USD","FMED","IE0004445239.USD","SG9999001176.USD","TARK","CRSP","LU0943347566.SGD","SG9999004303.SGD","LU1366333091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165924054","title":"Revolution Medicines宣布Rasonque™（Daraxonrasib）联合化疗获美国FDA突破性疗法认定，用于一线转移性胰腺癌治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1165924054","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165924054?lang=zh_cn&edition=full","pubTime":"2026-09-15 04:06","pubTimestamp":1789416374,"startTime":"0","endTime":"0","summary":"Revolution Medicines, Inc.今日宣布，其研发的创新药物Rasonque与化疗药物联用，已获得美国食品药品监督管理局授予的突破性疗法认定。这一认定针对的适应症为一线治疗转移性胰腺癌。此项突破性疗法认定标志着该联合治疗方案在临床试验中展现出显著的治疗潜力，有望为预后极差的转移性胰腺癌患者带来新的治疗选择。这一进展不仅为Revolution Medicines的研发管线注入了强劲动力，也让医学界对攻克胰腺癌这一顽固性疾病增添了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","PTH","CANC","IE0009355771.USD","IDNA","IE0002141913.USD","LU0109394709.USD","LU0320765992.SGD","IE0009354923.USD","IE00B2B36J28.USD","LU0889565916.HKD","BK4139","IE00BJT1NW94.SGD","RVMD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666571008","title":"阿斯利康股价盘后跌超2%，因其三期临床试验结果令人失望。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666571008?lang=zh_cn&edition=full","pubTime":"2026-09-12 04:23","pubTimestamp":1789158183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBB","FBT","IBRN","SBIO","PPH","BBP","LU1992135399.USD","IEHS","LU2322448957.HKD","LU1992135472.HKD","LU2272731865.HKD","MRNY","BME","PBE","XPH","IYH","BK4585","IE00B5TLWC47.USD","AZNH","PSCH","FTXH","LU2272731600.USD","BIOY","PBPH","PJP","BIB","LFSC","RSPH","MRNX","IDNA","TMED","LU2322448791.USD","XBIX","GNOM","LU2272731782.SGD","BBH","BK4588","IEIH","MEDI","CANC","SYNB","LU2473716301.USD","WDNA","RXL","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126485715","title":"因塞特医疗宣布：安大略省FAST计划为复发或难治性滤泡性淋巴瘤患者提供Minjuvi®（Tafasitamab）资金支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1126485715","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126485715?lang=zh_cn&edition=full","pubTime":"2026-09-10 21:03","pubTimestamp":1789045439,"startTime":"0","endTime":"0","summary":"因塞特医疗今日宣布了一项重大进展——其旗下药物Minjuvi已被纳入加拿大安大略省的FAST计划资助范围。这一举措专门针对那些饱受复发或难治性滤泡性淋巴瘤困扰的患者群体，为他们带来了新的治疗希望与切实的经济援助。而今，Minjuvi的加入无疑为该领域注入了全新活力。因塞特医疗的这项举措，不仅体现了其对改善患者可及性的执着追求，更彰显了公司在血液肿瘤学领域持续深耕的战略决心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","BK4550","INCY","BK4585","BK4532","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186962882","title":"Revolution Medicines获摩根士丹利首次覆盖，给予“增持”评级，目标价255美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1186962882","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186962882?lang=zh_cn&edition=full","pubTime":"2026-09-10 18:10","pubTimestamp":1789035009,"startTime":"0","endTime":"0","summary":"摩根士丹利近日宣布首次覆盖生物制药公司Revolution Medicines, Inc.，并给予其“增持”评级。该机构将目标股价设定为每股255美元。这一举措标志着华尔街主要投行对这家专注于研发创新疗法的企业前景持乐观态度。值得注意的是，摩根士丹利的这一评级和价格目标，为投资者提供了新的参考坐标。此前，市场对Revolution Medicines的关注度持续攀升，尤其在肿瘤治疗领域，其管线布局备受瞩目。此次覆盖报告的出炉，或将在短期内影响该股的市场情绪与交易动态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","LU0109394709.USD","BBH","IE0009355771.USD","PTH","LU0889565916.HKD","IE0002141913.USD","IE00B2B36J28.USD","IDNA","IE0009354923.USD","IE00B4R5TH58.HKD","BK4139","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU0320765992.SGD","RVMD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666554138","title":"Stifel上调Revolution Medicines目标价至230美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666554138","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666554138?lang=zh_cn&edition=full","pubTime":"2026-09-10 11:17","pubTimestamp":1789010271,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE0002141913.USD","IE00BJJMRZ35.SGD","BBH","IE00BJT1NW94.SGD","LU0109394709.USD","UUP","CANC","IE0009354923.USD","IE00B2B36J28.USD","RVMD","PTH","IE0009355771.USD","LU0889565916.HKD","LU0320765992.SGD","IE00B4R5TH58.HKD","IDNA","BK4139","IE00BFTCPJ56.SGD","UDN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0422},{"period":"1month","weight":0.0051},{"period":"3month","weight":0.2607},{"period":"6month","weight":0.4911},{"period":"1year","weight":0.8205},{"period":"ytd","weight":0.5918}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0017},{"period":"3month","weight":0.0524},{"period":"6month","weight":0.2099},{"period":"1year","weight":0.1605},{"period":"ytd","weight":0.125}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.000583},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.001958},{"month":3,"riseRate":0,"avgChangeRate":-0.043509},{"month":4,"riseRate":0.714286,"avgChangeRate":0.010336},{"month":5,"riseRate":0.571429,"avgChangeRate":0.017257},{"month":6,"riseRate":0.714286,"avgChangeRate":0.039341},{"month":7,"riseRate":0.625,"avgChangeRate":0.019072},{"month":8,"riseRate":0.625,"avgChangeRate":0.021221},{"month":9,"riseRate":0.375,"avgChangeRate":-0.022714},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.001378},{"month":11,"riseRate":0.857143,"avgChangeRate":0.076951},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.021129}],"exchange":"ARCA","name":"iShares Genomics Immunology and Healthcare ETF","nameEN":"iShares Genomics Immunology and Healthcare ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"iShares Genomics Immunology and Healthcare ETF(IDNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供iShares Genomics Immunology and Healthcare ETF(IDNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"iShares Genomics Immunology and Healthcare ETF,IDNA,iShares Genomics Immunology and Healthcare ETF股票,iShares Genomics Immunology and Healthcare ETF股票老虎,iShares Genomics Immunology and Healthcare ETF股票老虎国际,iShares Genomics Immunology and Healthcare ETF行情,iShares Genomics Immunology and Healthcare ETF股票行情,iShares Genomics Immunology and Healthcare ETF股价,iShares Genomics Immunology and Healthcare ETF股市,iShares Genomics Immunology and Healthcare ETF股票价格,iShares Genomics Immunology and Healthcare ETF股票交易,iShares Genomics Immunology and Healthcare ETF股票购买,iShares Genomics Immunology and Healthcare ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"iShares Genomics Immunology and Healthcare ETF(IDNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供iShares Genomics Immunology and Healthcare ETF(IDNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}